Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
AMGEN INC (AMGN)
Sector: Healthcare; Industry: Drug Manufacturers—General

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; and Adaptive Biotechnologies.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2012-11-29 BIONDI FRANK Director Sell 5,000 $88.10 $440,512 Yes
2012-11-26 OMENN GILBERT S Director Sell 26,000 $87.11 $2,264,985 Yes
2012-10-24 SHARER KEVIN W Director Sell 263,000 $88.13 $23,178,598 Yes
2012-09-11 SHARER KEVIN W Director Sell 349,625 $83.96 $29,355,365 Yes
2012-08-30 SCHAEFFER LEONARD D Director Sell 5,000 $83.25 $416,254 Yes
2012-08-24 PELHAM JUDITH C Director Sell 5,000 $84.37 $421,832 Yes
2012-08-09 REASON J PAUL Director Sell 4,500 $81.93 $368,692 No
2012-08-01 RICHO ANNA SVP & CCO Sell 5,125 $83.06 $425,698 Yes
2012-07-31 Dittrich Thomas J.W. VP, Finance & CAO Sell 32,150 $82.69 $2,658,387 Yes
2012-07-30 SCOTT DAVID J SVP, Gen. Counsel & Secy. Sell 143,500 $83.67 $12,006,578 Yes
2012-07-27 RICHO ANNA SVP & CCO Sell 7,875 $81.81 $644,230 Yes
2012-07-27 MCNAMEE BRIAN M SVP, Human Resources Sell 85,598 $82.73 $7,081,859 Yes
2012-07-27 Harper Sean E EVP, Research & Development Sell 39,900 $82.33 $3,285,087 Yes
2012-07-30 BONANNI FABRIZIO EVP, Operations Sell 315,148 $82.22 $25,912,279 Yes
2012-07-27 SHARER KEVIN W Director Sell 128,000 $82.68 $10,583,347 Yes
2012-07-27 BIONDI FRANK Director Sell 21,000 $82.30 $1,728,300 Yes
2012-05-17 MCNAMEE BRIAN M SVP, Human Resources Sell 3,334 $70.79 $236,026 No
2012-05-18 PELHAM JUDITH C Director Sell 16,000 $69.06 $1,104,989 Yes
2012-05-03 BEIER DAVID W SVP, Global Govt Affairs Sell 55,000 $70.72 $3,889,369 Yes
2012-05-03 BONANNI FABRIZIO EVP, Operations Sell 6,572 $70.86 $465,679 No
2012-05-03 SHARER KEVIN W Chairman of the Board and CEO Sell 7,000 $71.09 $497,626 No
2012-05-01 RICHO ANNA SVP & CCO Sell 20,000 $70.78 $1,415,571 Yes
2012-04-26 SHARER KEVIN W Chairman of the Board and CEO Sell 130,425 $70.86 $9,242,181 Yes
2012-04-26 MCNAMEE BRIAN M SVP, Human Resources Sell 2,500 $70.85 $177,125 No
2012-03-01 BIONDI FRANK Director Sell 5,000 $67.57 $337,826 Yes
2012-02-13 PELHAM JUDITH C Director Sell 5,000 $68.30 $341,500 Yes
2012-02-07 BEIER DAVID W SVP, Global Govt Affairs Sell 20,000 $68.88 $1,377,678 Yes
2012-02-02 PERLMUTTER ROGER M EVP, Research & Development Sell 75,000 $69.83 $5,237,325 Yes
2012-02-01 BONANNI FABRIZIO EVP, Operations Sell 7,745 $69.63 $539,321 No
2012-01-30 Dittrich Thomas J.W. VP, Finance & CAO Sell 26,150 $68.26 $1,784,931 Yes

Insider Smart

CARNIVAL CORP (CCL) - Cruislines $CCL $NCLH $RCL took a huge beat due to the pandemic, concerns of bankruptcy were raised. Among the three dominating companies in the industry, $CCL is the first one bought by insiders, such a bold move would definitely boost investor confidence.

Insider Smart

PROSPECT CAPITAL CORP (PSEC) - PSEC is the 2nd most bought stock of the past 90 days by insiders, CEO seems very confident about the company.